Brilinta Tablets and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Brilinta Tablets and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ticagrelor
Brand name: Brilinta
Synonyms: Brilinta
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brilinta Tablets-Insulin degludec
- Brilinta Tablets-Insulin Degludec (U-100) Prefilled Pens
- Brilinta Tablets-Insulin Degludec (U-100) Vials
- Brilinta Tablets-Insulin Degludec (U-200) Prefilled Pens
- Brilinta Tablets-Insulin degludec and liraglutide
- Brilinta Tablets-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Brimonidine
- Insulin aspart, recombinant Subcutaneous-Brimonidine and brinzolamide ophthalmic
- Insulin aspart, recombinant Subcutaneous-Brimonidine and Timolol
- Insulin aspart, recombinant Subcutaneous-Brimonidine and timolol ophthalmic
- Insulin aspart, recombinant Subcutaneous-Brimonidine ophthalmic
- Insulin aspart, recombinant Subcutaneous-Brimonidine Tartrate eent